跳至主要内容
临床试验/NCT05247879
NCT05247879已完成不适用

Clinical Effectiveness and Safety of a Novel Oral Rehydration Solution in Children Ages 1-5 Years Presenting to Hospital With Mild or Moderate Dehydration Gastroenteritis: Randomized, Open-label, Controlled Trial

Mead Johnson Nutrition4 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年6月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
4
主要终点
Clinically assessed adequate rehydration based on clinical judgement of change in or absence of presenting symptoms from baseline (i.e. heart rate, urine output, etc.)

研究概览

简要总结

This is a randomised, controlled, open-label study to determine the clinical effectiveness and safety of a novel ORS compared with a commercial ORS in children 1 to 5 years of age attending emergency departments with gastroenteritis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
1 Year 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 1 to 5 years of age, inclusive at randomization
  • Hospitalized with mild to moderate dehydration due to ongoing diarrhea
  • Signed informed consent obtained for child's participation in the study

排除标准

  • Severe dehydration and/or use of IV fluids for current hospitalization
  • Experiencing bloody diarrhea or diarrhea due to Cholera, Dysentery, persistent/chronic diarrhea, diarrhea with severe malnutrition, diarrhea associated with recent antibiotic use
  • In the opinion of the Investigator, not suitable for treatment with ORS
  • Have any underlying disease or disorder that may, in the opinion of the Investigator, affect the results of the study if they were enrolled (includes, but is not limited to, gastrointestinal disorders such as Crohn's disease or other inflammatory bowel disease or congenital malabsorption disorders)
  • Cause of the dehydration is something other than diarrhea
  • Known to be allergic to any of the components of the Investigational ORS

结局指标

主要结局

Clinically assessed adequate rehydration based on clinical judgement of change in or absence of presenting symptoms from baseline (i.e. heart rate, urine output, etc.)

时间窗: every 4 hours up to 24 hours or hospital discharge, whichever occurs first

Assess change in clinical hydration status from presenting baseline status

次要结局

  • Study ORS intake (units)(Every 4 hours up to 24 hours or hospital discharge, whichever occurs first)
  • Use of IV fluids(up to 24 hours or hospital discharge, whichever occurs first)
  • Parent satisfaction questionnaire(baseline and 24 hours or hospital discharge, whichever occurs first)
  • Frequency of vomiting(every 4 hours up to 24 hours or hospital discharge, whichever occurs first)
  • Record patient use of antibiotics during hospitalization(up to 24 hours or hospital discharge, whichever comes first)
  • Participant comfort questionaire(baseline and 24 hours or hospital discharge, whichever occurs first)
  • Frequency episodes of urination(every 4 hours up to 24 hours or hospital discharge, whichever occurs first)
  • Time ready for discharge(At discharge or 48 hours whichever occurs first)
  • Frequency of liquid/watery stool(every 4 hours up to 24 hours or hospital discharge, whichever occurs first)
  • Medically confirmed adverse events collected throughout the study period(0 hours through 7 days post discharge)
  • Weight(Every 4 hours up to 24 h or at hospital discharge, whichever occurs first)
  • Time to resolution of liquid/water stool(up to 24 hours or hospital discharge, whichever comes first)
  • Clinical Assessment of patient's hydration status based on presenting symptoms (i.e. heart rate, urine output, etc.)(Baseline)
  • Stool for bacterial pathogen culture and viral antigens(up to 24 hours or hospital discharge, whichever comes first)

研究者

发起方
Mead Johnson Nutrition
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验